Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Zai Lab Ltd ADR (NQ: ZLAB ) 24.62 -0.99 (-3.87%) Streaming Delayed Price Updated: 4:00 PM EDT, Oct 3, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Zai Lab Ltd ADR < Previous 1 2 ... 4 5 6 7 8 9 10 11 Next > 3 More Mid-Cap Biotechs The Street Sees Doubling February 22, 2023 According to Wall Street research groups, these three mid-cap biotechs have 2x potential. It’s for the investor to decide if the upside justifies the risk. Via MarketBeat Zai Lab Announces NDA Acceptance of Sulbactam-Durlobactam (SUL-DUR) for Infections Caused by Acinetobacter baumannii in China by the NMPA February 22, 2023 From Zai Lab Limited Via GlobeNewswire Mixed Signals On Valentine's Day: How Stocks Are Reacting To January Inflation Data February 14, 2023 Inflation cooled slightly in January, but saw increases in some areas due to the impact of surging food, energy and shelter prices on consumers, the U.S Labor Department said Tuesday. Via Benzinga What's Going On With Zai Lab Stock January 04, 2023 Zai Lab Ltd - ADR (NASDAQ: ZLAB) shares are trading higher by 7.04% to $33.01 Wednesday morning. Via Benzinga Zai Lab to Announce Full-Year Financial Results and Corporate Updates on March 1, 2023 February 09, 2023 Company to Host Conference Call and Webcast on March 2, 2023, at 8:00 a.m. ET From Zai Lab Limited Via GlobeNewswire Zai Lab Announces Participation in February Investor Conferences January 31, 2023 From Zai Lab Limited Via GlobeNewswire Zai Lab Announces NDA for Sulbactam-Durlobactam (SUL-DUR) Granted Priority Review by China’s NMPA January 30, 2023 From Zai Lab Limited Via GlobeNewswire Zai Lab Announces Inclusion of QINLOCK® (ripretinib) and NUZYRA® (omadacycline) in China’s National Reimbursement Drug List January 18, 2023 From Zai Lab Limited Via GlobeNewswire Zai Lab Appoints Michel Vounatsos To Its Board of Directors January 09, 2023 From Zai Lab Limited Via GlobeNewswire Stock Market Mostly Higher Amid Jobs Report; Tesla Price Cuts, GE Spinoff In Focus: Weekly Review January 06, 2023 The major indexes rallied Friday on the jobs report and services data. Via Investor's Business Daily Why Shares of Zai Lab Soared This Week January 05, 2023 A strong phase-3 clinical trial boosted investors' hopes for the Chinese biotech company. Via The Motley Fool Why ABVC BioPharma Shares Are Trading Higher By 129%? Here Are Other Stocks Moving In Thursday's Mid-Day Session January 05, 2023 Gainers Bellerophon Therapeutics, Inc. (NASDAQ: BLPH) shares surged 179.3% to $2.4585 after the company announced that it has entered into a license agreement for the development and commercialization... Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session January 05, 2023 Via Benzinga Novocure Stock Surges As Tumor Treating Fields Shows Overall Survival In Lung Cancer Patients January 05, 2023 Via Benzinga This Good News on Cancer Sent 2 Nasdaq Stocks Soaring January 05, 2023 Biotech investors are optimistic about the prospects for a potential treatment. Via The Motley Fool US Stocks Open Lower; Dow Tumbles 300 Points January 05, 2023 U.S. stocks traded lower this morning, with the Dow Jones dropping more than 300 points on Thursday. Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session January 05, 2023 Via Benzinga Zai Lab and Novocure Announce Pivotal LUNAR Study in Non-Small Cell Lung Cancer Met Primary Overall Survival Endpoint January 05, 2023 From Zai Lab Limited Via GlobeNewswire Zai Lab Announces the Appointment of Dr. Rafael G. Amado as President, Head of Global Oncology Research and Development January 03, 2023 From Zai Lab Limited Via GlobeNewswire Zai Lab Announces Participation in January Investor Conferences December 20, 2022 From Zai Lab Limited Via GlobeNewswire Zai Lab Presents Interim Overall Survival Data for ZEJULA® (niraparib) from the NORA Phase 3 Study at the ESMO Virtual Plenary December 15, 2022 From Zai Lab Limited Via GlobeNewswire Why Autolus Therapeutics Shares Are Trading Lower By Around 26%; Here Are 28 Stocks Moving Premarket December 09, 2022 Gainers Baudax Bio, Inc. (NASDAQ: BXRX) shares rose 48.2% to $6.03 in pre-market trading after jumping over 20% on Thursday. Baudax Bio initiated Phase II clinical trial evaluating BX1000 in patients... Via Benzinga Broadcom, DocuSign And Some Other Big Stocks Moving Higher In Today's Pre-Market Session December 09, 2022 U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session. Via Benzinga Zai Lab Partner Mirati Therapeutics Presents Late-Breaking Results Evaluating Concurrent Adagrasib and Pembrolizumab in First-Line Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC) December 05, 2022 From Zai Lab Limited Via GlobeNewswire Mirati Plays Catch-Up With Amgen, Gilead's 2nd Try With AIDS Drug, Cytokinetics' Adcom Test And More: Key Nov FDA Decisions For Biotech Investors December 02, 2022 Food and Drug Administration decisions and advisory committee verdicts slated for November were mostly positive. New molecular entity approvals so far this year trail 2021’s tally by about 35%. Via Benzinga Chinese Stocks Are Surging Today: What's Going On? November 29, 2022 Shares of several Chinese companies are trading higher Tuesday amid hopes that protests in China could spark an easing of COVID restrictions. Via Benzinga Unity Software, Amazon, Doximity And Other Big Gainers From Friday November 14, 2022 U.S. stocks closed higher on Friday, with the Nasdaq Composite jumping more than 200 points. Here is the list of some big stocks recording gains in the previous session. Via Benzinga Why Tattooed Chef Shares Dipped Around 15%; Here Are 95 Biggest Movers From Friday November 14, 2022 Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 56.6% to settle at $19.10 on Friday. Via Benzinga Why Compass Shares Are Trading Higher By Over 56%? Here Are 63 Stocks Moving In Friday's Mid-Day Session November 11, 2022 Gainers Snail, Inc. (NASDAQ: SNAL) shares jumped 74.9% to $3.9350 after the company announced a $5 million share repurchase program. Via Benzinga Zai Lab Announces Third Quarter 2022 Financial Results and Corporate Updates November 09, 2022 From Zai Lab Limited Via GlobeNewswire < Previous 1 2 ... 4 5 6 7 8 9 10 11 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.